Board of Trustees
The Harvard Clinical Research Institute (HCRI) is a 501(c)(3) not-for-profit corporation created by the Harvard Medical School, Partners HealthCare and the Beth Israel Deaconess Medical Center. Its governance consists of a Board of Trustees comprised of leading representatives from these institutions.
Chris Colecchi
Vice President, Research Ventures & Licensing – Partners HealthCare System Inc.
Jules Dienstag, MD
Professor of Medicine – Harvard Medical School
Dean, Medical Education – Massachusetts General Hospital
Raphael Dolin, MD
Dean, Academic and Clinical Programs Maxwell Finland Professor of Medicine – Harvard Medical School
Steven Freedman, MD
Director, The Pancreas Center Division of Gastroenterology – Beth Israel Deaconess Medical Center
Chair, Clinical Research Strategy Committee – Beth Israel Deaconess Medical Center
Program Director, General Clinical Research Center – Beth Israel Deaconess Medical Center
Jay Pieper
Vice President, Corporate Development and Treasury Affairs – Partners HealthCare System Inc.
Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief – Massachusetts General Hospital
Stanley Cobb Professor of Psychiatry – Harvard Medical School
Stuart A. Rosenberg, MD
President and CEO, Harvard Medical Faculty Physicians – Beth Israel Deaconess Medical Center
Michael E. Weinblatt, MD
Professor of Medicine, Rheumatology and Immunology – Brigham and Women's Hospital
Mark L. Zeidel, MD
Chair, Department of Medicine – Beth Israel Deaconess Medical Center
